LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code 0075U.
Signal breakdown
12 shown · 12 total in platform
Critical
0%
High
25%
Routine
75%
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Policy LCD-L38337 · Clinical Laboratory
New coverage for pharmacogenomics testing effective 10/02/2025
Policy LCD-L38394 · Clinical Laboratory
New pharmacogenomics testing affects billing from 2025.
Policy LCD-L38335 · Clinical Laboratory
Prepare for changes in pharmacogenomics testing billing.
Policy LCD-L38294 · Clinical Laboratory
New LCD for Pharmacogenomics Testing effective 10/02/2025
Policy LCD-L38351 · Oncology
New guidelines for repeat germline testing could impact reimbursements.
Policy LCD-L38680 · Clinical Laboratory
WPS LCD L38680 for allograft rejection molecular testing now retired.
Policy LCD-L38435 · Clinical Laboratory
New billing guidelines for Pharmacogenomics Testing effective 2025.
Policy LCD-L38288 · Oncology
New LCD may impact repeat germline testing reimbursements.
Policy LCD-L38353 · Clinical Laboratory
New LCD on germline testing impacts billing practices.
Audit documentation
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.